Evaluation of the Effect of the Drug "Mumiaee" on the Union Period of Distal Radius Fractures

Evaluation of the Effect of the Drug "Mumiaee" on the Union Period of Distal Radius Fractures: A Randomized Clinical Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191216045758N1

Enrollment

Registered

2020-10-21

Start date

2020-10-05

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Distal Right Radius Fracture. Condition 2: Distal Left Radius Fracture. Unspecified fracture of the lower end of right radius, initial encounter for closed fracture Unspecified fracture of the lower end of left radius, initial encounter for closed fracture

Interventions

Intervention 1: Intervention group: consists of 22 patients who will receive 4 capsules of Mumiaee (Shilajit) containing 250 mg of the substance (a total of 1000 mg per day) every 6 hours, daily for 1

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Closed Fractures Fernandez Fractures type 1-3 that are fixed by PCP or External Fixators. Lack of Rheumatoid Disease, Diabetes and Immune Deficiency in the past medical history of the participants.

Exclusion criteria

Exclusion criteria: Pathological Fractures Underlying Bones Diseases such as Osteopetrosis Unexpected Special Medical Conditions

Design outcomes

Primary

Measure	Time frame
Union Period of Distal Radius Fracture. Timepoint: At the beginning of the study and on the weeks 2, 4, 6, 8, 10, 12. Method of measurement: Wrist X-Ray.	—

Secondary

Measure	Time frame
Wrist Range of Motion. Timepoint: On the weeks: 2, 4, 6, 8, 10 and 12. Method of measurement: By using Goniometer.;Wrist Pain and Disability in Activities of Daily Living. Timepoint: After the initial treatment and the start of Mumiaee (Shilajit) consumption on the weeks 6 and 12. Method of measurement: By using Patient-Rated Wrist Evaluation questionnaire.;Physical Function of Upper Limb. Timepoint: At the start of Mumiaee (Shilajit) consumption on the weeks 6 and 12. Method of measurement: By using Quick Disabilities of Arm, Shoulder and Hand questionnaire.;Patient's Wrist Pain. Timepoint: At the start of Mumiaee (Shilajit) consumption on the weeks 6 and 12. Method of measurement: By Visual Analog Scale Pain questionnaire.;Hand Grip Strength. Timepoint: After the initial treatment and the start of Mumiaee (Shilajit) consumption on the weeks 6 and 12. Method of measurement: By Orthopedic Equipment Dynamometer.	—

Measure

Time frame

Wrist Range of Motion. Timepoint: On the weeks: 2, 4, 6, 8, 10 and 12. Method of measurement: By using Goniometer.;Wrist Pain and Disability in Activities of Daily Living. Timepoint: After the initial treatment and the start of Mumiaee (Shilajit) consumption on the weeks 6 and 12. Method of measurement: By using Patient-Rated Wrist Evaluation questionnaire.;Physical Function of Upper Limb. Timepoint: At the start of Mumiaee (Shilajit) consumption on the weeks 6 and 12. Method of measurement: By using Quick Disabilities of Arm, Shoulder and Hand questionnaire.;Patient's Wrist Pain. Timepoint: At the start of Mumiaee (Shilajit) consumption on the weeks 6 and 12. Method of measurement: By Visual Analog Scale Pain questionnaire.;Hand Grip Strength. Timepoint: After the initial treatment and the start of Mumiaee (Shilajit) consumption on the weeks 6 and 12. Method of measurement: By Orthopedic Equipment Dynamometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Moradi

Mashhad University of Medical Sciences

moradial@mums.ac.ir+98 51 3854 3031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026